Gemmer Asset Management’s Cellectis CLLS Stock Holding History

Gemmer Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7	Closed	–	–	1352
2019 Q3	$0	Buy	+7	New	+$94	﹤0.01%	1394

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gemmer Asset Management's CLLS Position: Q4 2019 in Review

Gemmer Asset Management sold out of Cellectis (CLLS) in Q4 2019, closing a stake of 7 shares.

Gemmer Asset Management first reported a position in CLLS in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 60 funds tracked by Wall St. Rank hold CLLS as of Q4 2019.

Gemmer Asset Management reported no remaining Cellectis position as of Q4 2019 after selling out during the quarter.
Gemmer Asset Management sold 7 Cellectis shares in Q4 2019.
Gemmer Asset Management first reported a position in Cellectis in Q3 2019 and held it in 1 quarter.
Gemmer Asset Management's Cellectis position peaked at $0 in Q3 2019.
60 funds tracked by Wall St. Rank held Cellectis as of Q4 2019.

Based on Gemmer Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.